| |
| Learn
more about NeuroQTM by viewing a WebEx (audio/visual) presentation |
Three
of the top PET physicians
in the country discuss
the clinical benefits of
using PET in diagnosing
Alzheimer's Disease
and expanding neurology
referrals with the help
of NeuroQ.
Note: there is a short
delay before
presentation starts. You
may fast forward
past
this using the WebEx control
panel.
|
|
|
 |
|
Positron Emission Tomography is a non-invasive,
advanced diagnostic imaging procedure that
can provide unique information to aid in
the differential diagnosis of Alzheimer's
disease versus other dementias as well
as assist with the management of stroke,
brain tumors, and epileptic seizures. Because
Alzheimer's Disease coverage is very specific,
DMS Imaging offers a coverage
criteria guide and a checklist/scan
order form to help you educate and
work with your referring physicians.
Since glucose is the primary source of energy
for cells in the brain, the radiopharmaceutical
FDG, a glucose derivative, helps to create
a normal versus abnormal map of brain function,
as imaged in a PET scan. Distinctive patterns
of glucose metabolism assist physicians in
accurately diagnosing patients and treating
them appropriately.
For additional diagnostic confidence
and to differentiate your PET brain
imaging services
in your local market try using quantification
tools like NeuroQTM and
PET Foundations' Home
Study CD - Neurology Edition, available
through DMS Imaging and Cardinal Health.
Find out more about Alzheimer's
Disease at the Alzheimer's Association
website: www.alz.org.
|
